Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corp (NQ: LQDA )

12.06 -0.42 (-3.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 637,054
Open 12.35
Bid (Size) 12.01 (5)
Ask (Size) 12.40 (4)
Prev. Close 12.48
Today's Range 11.99 - 12.52
52wk Range 5.710 - 16.99
Shares Outstanding 76,027,776
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
From Liquidia Corporation
Via GlobeNewswire

Performance

YTD
+4.60%
+4.60%
1 Month
-18.68%
-18.68%
3 Month
-18.57%
-18.57%
6 Month
+92.34%
+92.34%
1 Year
+45.83%
+45.83%

More News

Read More
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
From Liquidia Corporation
Via GlobeNewswire
The Analyst Landscape: 5 Takes On Liquidia
Via Benzinga
Unveiling 6 Analyst Insights On Liquidia
Via Benzinga
Recap: iShares $ Corp Bond UCITS ETF Q4 Earnings
Via Benzinga
Topics ETFs
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
From Liquidia Corporation
Via GlobeNewswire
Liquidia Earnings Preview
Via Benzinga
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For March 13, 2024
Via Benzinga
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
From Liquidia Corporation
Via GlobeNewswire
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
Via Benzinga
Exposures Product Safety
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
From Liquidia Corporation
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Liquidia Corporation Announces Updates to Operations Leadership
From Liquidia Corporation
Via GlobeNewswire
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
From Liquidia Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.